
|Articles|August 28, 2019
ASRS 2019 Street Team: Charles C. Wykoff, MD, PhD
Author(s)OT Staff Reports
ICMYI: Dr. Wykoff discusses results from his ASRS presentation
Advertisement
Charles C. Wykoff, MD, PhD, discusses results from his presentation, "Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes from the Randomized RECOVERY Trial.” He delivered his presentation at the 2019 annual meeting of the American Society of Retina Specialists.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
The Atrophy Advisor: An online tool to inform GA treatment decisions
2
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
3
FLORetina 2025: Updates on tinlarebant in adolescent Stargardt disease
4
Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases
5








































